Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 754 | 3018 | 29.1 | 80% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 976 | 10158 | JOURNAL OF HEART AND LUNG TRANSPLANTATION//ANTIBODY MEDIATED REJECTION//HEART TRANSPLANTATION |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ANTIBODY MEDIATED REJECTION | Author keyword | 324 | 67% | 10% | 293 |
| 2 | C4D | Author keyword | 138 | 63% | 5% | 139 |
| 3 | HLA ANTIBODIES | Author keyword | 130 | 64% | 4% | 128 |
| 4 | DONOR SPECIFIC ANTIBODIES | Author keyword | 120 | 68% | 3% | 105 |
| 5 | DONOR SPECIFIC ANTIBODY | Author keyword | 107 | 77% | 2% | 72 |
| 6 | HLA ANTIBODY | Author keyword | 79 | 76% | 2% | 55 |
| 7 | CROSSMATCH | Author keyword | 79 | 74% | 2% | 59 |
| 8 | ANTI HLA ANTIBODIES | Author keyword | 65 | 60% | 2% | 70 |
| 9 | HUMORAL REJECTION | Author keyword | 60 | 54% | 3% | 78 |
| 10 | TRANSPLANT GLOMERULOPATHY | Author keyword | 51 | 66% | 2% | 48 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ANTIBODY MEDIATED REJECTION | 324 | 67% | 10% | 293 | Search ANTIBODY+MEDIATED+REJECTION | Search ANTIBODY+MEDIATED+REJECTION |
| 2 | C4D | 138 | 63% | 5% | 139 | Search C4D | Search C4D |
| 3 | HLA ANTIBODIES | 130 | 64% | 4% | 128 | Search HLA+ANTIBODIES | Search HLA+ANTIBODIES |
| 4 | DONOR SPECIFIC ANTIBODIES | 120 | 68% | 3% | 105 | Search DONOR+SPECIFIC+ANTIBODIES | Search DONOR+SPECIFIC+ANTIBODIES |
| 5 | DONOR SPECIFIC ANTIBODY | 107 | 77% | 2% | 72 | Search DONOR+SPECIFIC+ANTIBODY | Search DONOR+SPECIFIC+ANTIBODY |
| 6 | HLA ANTIBODY | 79 | 76% | 2% | 55 | Search HLA+ANTIBODY | Search HLA+ANTIBODY |
| 7 | CROSSMATCH | 79 | 74% | 2% | 59 | Search CROSSMATCH | Search CROSSMATCH |
| 8 | ANTI HLA ANTIBODIES | 65 | 60% | 2% | 70 | Search ANTI+HLA+ANTIBODIES | Search ANTI+HLA+ANTIBODIES |
| 9 | HUMORAL REJECTION | 60 | 54% | 3% | 78 | Search HUMORAL+REJECTION | Search HUMORAL+REJECTION |
| 10 | TRANSPLANT GLOMERULOPATHY | 51 | 66% | 2% | 48 | Search TRANSPLANT+GLOMERULOPATHY | Search TRANSPLANT+GLOMERULOPATHY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DONOR SPECIFIC ANTIBODIES | 300 | 76% | 7% | 213 |
| 2 | HUMORAL REJECTION | 238 | 64% | 8% | 230 |
| 3 | MEDIATED REJECTION | 225 | 59% | 8% | 255 |
| 4 | ACUTE HUMORAL REJECTION | 213 | 66% | 7% | 197 |
| 5 | CROSS MATCH | 190 | 60% | 7% | 207 |
| 6 | HLA ANTIBODIES | 187 | 51% | 9% | 259 |
| 7 | ANTIBODY MEDIATED REJECTION | 136 | 42% | 8% | 250 |
| 8 | HIGHLY SENSITIZED PATIENTS | 133 | 74% | 3% | 98 |
| 9 | POSITIVE CROSS MATCH | 117 | 62% | 4% | 121 |
| 10 | PANEL REACTIVE ANTIBODY | 104 | 70% | 3% | 87 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis | 2007 | 257 | 50 | 94% |
| A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection | 2015 | 2 | 95 | 87% |
| Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches | 2014 | 17 | 125 | 76% |
| The impact of donor-specific anti-HLA antibodies on late kidney allograft failure | 2012 | 58 | 58 | 86% |
| Anti-HLA antibodies after solid organ transplantation | 2000 | 243 | 50 | 72% |
| Strategies to increase the donor pool and access to kidney transplantation: an international perspective | 2015 | 3 | 41 | 37% |
| The Treatment of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients-A Systematic Review | 2012 | 38 | 51 | 94% |
| Transplant glomerulopathy | 2008 | 115 | 21 | 76% |
| Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms | 2014 | 9 | 62 | 79% |
| Deciphering antibody-mediated rejection: new insights into mechanisms and treatment | 2010 | 62 | 10 | 100% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EUROTRANSPLANT REFERENCE | 13 | 71% | 0.3% | 10 |
| 2 | TISSUE TYPING | 10 | 11% | 2.9% | 89 |
| 3 | TRANSPLANT IMMUNOL | 10 | 16% | 1.9% | 56 |
| 4 | VON LIEBIG TRANSPLANT | 9 | 64% | 0.3% | 9 |
| 5 | TRANSPLANT MASSACHUSETTS GEN HOSP | 9 | 83% | 0.2% | 5 |
| 6 | HISTOCOMPATIBILITE | 9 | 52% | 0.4% | 12 |
| 7 | TRANSPLANT IMMUNOTHER Y PROGRAM | 8 | 70% | 0.2% | 7 |
| 8 | UOC IMMUNOHEMATOL TRANSFUS MED TRANSPLANT I | 8 | 75% | 0.2% | 6 |
| 9 | TRANSPLANTAT PATHOL | 8 | 29% | 0.8% | 24 |
| 10 | COMPREHENS TRANSPLANT TRANSPLANT IMMUNOL | 8 | 100% | 0.2% | 5 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000196508 | REG REFERENCE IMMUNOGENET TRANSPLANTAT IMMU//GRAFT ISCHEMIC TIME//HLA MATCHMAKER |
| 2 | 0.0000185133 | ABO INCOMPATIBLE//ABO INCOMPATIBLE KIDNEY TRANSPLANTATION//ABO INCOMPATIBILITY |
| 3 | 0.0000151934 | SUBCLINICAL REJECTION//PROTOCOL BIOPSY//ALBERTA TRANSPLANT PL GENOM |
| 4 | 0.0000103585 | GRAFT INTOLERANCE SYNDROME//ALLOGRAFT NEPHRECTOMY//RENAL RETRANSPLANTATION |
| 5 | 0.0000090591 | BLOOD TRANSFUSION EFFECT//IMMUNOCYTOBIOL SECT//DONOR SPECIFIC TRANSFUSION |
| 6 | 0.0000081855 | ANTI ENDOTHELIAL CELL ANTIBODIES//ANTI ENDOTHELIAL CELL ANTIBODY//ANTIENDOTHELIAL CELL ANTIBODIES |
| 7 | 0.0000063713 | LYMPHOCYTOTOXIC CROSSMATCH//ANNETTE C HAROLD C SIMMONS TRANSPLANT//LIVER ALLOGRAFT REJECTION |
| 8 | 0.0000057180 | BASILIXIMAB//THYMOGLOBULIN//DACLIZUMAB |
| 9 | 0.0000048125 | CARDIAC ALLOGRAFT VASCULOPATHY//ALLOGRAFT VASCULOPATHY//GRAFT ARTERIOSCLEROSIS |
| 10 | 0.0000046145 | INDIRECT ALLORECOGNITION//IMMUNOGENET TRANSPLANTAT//ALLORECOGNITION |